Table 2.
1,5-Anhydroglucitol
|
Fructosamine
|
Glycated Albumin
|
||||
---|---|---|---|---|---|---|
Model# | R2 | Model | R2 | Model | R2 | |
Overall (N = 1719) | ||||||
Best Fit | ||||||
A1c | 5.3903 + 5.5048/x | 0.21 | 247.480 − 90.745ln(x) + 8.509(ln(x))2 | 0.46 | 26.275 − 17.612ln(x) + 3.720(ln(x))2 | 0.54 |
FG | 212.182 − 66.594ln(x) + 10.153(ln(x))2 | 0.17 | 553.548 − 1.898e+05/x + 1.98e+07/x2 | 0.39 | 7.8278 + 7.3595x − 0.001262x3 | 0.41 |
Linear | ||||||
A1c | 6.4828 − 0.0388x | 0.10 | 2.0958 + 0.0157x | 0.39 | 2.9425 + 0.2011x | 0.52 |
FG | 128.8306 − 1.1732x | 0.09 | −2.3199 + 0.4678x | 0.35 | 29.4777 + 5.5447x | 0.39 |
History of Diabetes (N =343)* | ||||||
Best Fit | ||||||
A1c | 5.7696 + 8.8587/x − 5.1029/x2 | 0.33 | 250.611 − 90.873ln(x) + 8.443(ln(x))2 | 0.61 | 4.163 + 0.1287x + 3.82e+05x3 | 0.71 |
FG | 208.73 − 32.56ln(x) + 0.9807(ln(x))2 | 0.23 | 426.93 − 1.2077e+05/x + 1.14e+07/x2 | 0.32 | 130.8 − 8.837x + 0.712x2 − 0.0108x3 | 0.37 |
Linear | ||||||
A1c | 7.7246 − 0.0770x | 0.20 | 1.8763 + 0.0177x | 0.56 | 3.1198 + 0.2032x | 0.69 |
FG | 170.7132 − 2.5411x | 0.20 | 14.4649 + 0.4504x | 0.32 | 57.0838 + 4.5410x | 0.30 |
No History of Diabetes (N = 1376)* | ||||||
Best Fit | ||||||
A1c | 5.5935 + 0.1047/x + 4.5559/x2 | 0.04 | 9.5088 − 0.03831x + 9.25e+5x2 | 0.12 | 14.8959 + 0.5714x − 6.5423ln(x) | 0.16 |
FG | 101.7556 + 148.9338/x2 | 0.05 | 298.1406 − 1.8538x + 0.004328x2 | 0.24 | 603.933 + 27.0403x − 333.704ln(x) | 0.28 |
Linear | ||||||
A1c | 5.8152 − 0.0101x | 0.01 | 4.0437 + 0.0069x | 0.07 | 3.9098 + 0.1267x | 0.13 |
FG | 106.6068 − 0.2107x | 0.01 | 42.2954 + 0.2630x | 0.12 | 43.5650 + 4.3574x | 0.18 |
Abbreviations: A1c, hemoglobin A1c; FG, fasting glucose.
Diabetic status determined by self-reported history.
Modeling was performed using glucose concentrations expressed in mg/dL, 1,5-Anhydroglucitol concentrations in μg/mL, fructosamine concentrations in μmol/L and glycated albumin in %.